EquityPanditβs Outlook for Sun PharmaΒ for the week Β (JuneΒ 05, 2017 β JuneΒ 09, 2017) : SUN PHARMA: SUN PHARMA closed the week on negative note...
Sun Pharmaceutical Industries has said that the US heath regulator has accepted biologics licence application (BLA) for tildrakizumab for the treatment of psoriasis. Sun Pharma...